BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8562504)

  • 1. The induction of human T cell unresponsiveness by soluble anti-CD3 mAb requires T cell activation.
    Willems F; Andris F; Xu D; Abramowicz D; Wissing M; Goldman M; Leo O
    Int Immunol; 1995 Oct; 7(10):1593-8. PubMed ID: 8562504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells.
    Carpenter PA; Pavlovic S; Tso JY; Press OW; Gooley T; Yu XZ; Anasetti C
    J Immunol; 2000 Dec; 165(11):6205-13. PubMed ID: 11086054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activation through the TCR-CD3 complex affects the requirement for costimulation of human T cells.
    Kawaguchi M; Eckels DD
    Hum Immunol; 1995 Jun; 43(2):136-48. PubMed ID: 7591873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3.
    Bonnefoy-Berard N; Revillard JP
    J Heart Lung Transplant; 1996 May; 15(5):435-42. PubMed ID: 8771497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies directed to different epitopes in the CD3-TCR complex induce different states of competence in resting human T cells.
    Schwinzer R; Franklin RA; Domenico J; Renz H; Gelfand EW
    J Immunol; 1992 Mar; 148(5):1322-8. PubMed ID: 1371524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD3 antibodies OKT3 and hOKT3gamma1(Ala-Ala) induce proliferation of T cells but impair expansion of alloreactive T cells; aspecifc T cell proliferation induced by anti-CD3 antibodies correlates with impaired expansion of alloreactive T cells.
    Popma SH; Griswold DE; Li L
    Int Immunopharmacol; 2005 Jan; 5(1):155-62. PubMed ID: 15589476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
    Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
    Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3.
    Ceuppens JL; Baroja ML
    J Immunol; 1986 Sep; 137(6):1816-21. PubMed ID: 3091691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HuM291, a humanized anti-CD3 antibody, is immunosuppressive to T cells while exhibiting reduced mitogenicity in vitro.
    Cole MS; Stellrecht KE; Shi JD; Homola M; Hsu DH; Anasetti C; Vasquez M; Tso JY
    Transplantation; 1999 Aug; 68(4):563-71. PubMed ID: 10480417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo.
    Alegre ML; Peterson LJ; Xu D; Sattar HA; Jeyarajah DR; Kowalkowski K; Thistlethwaite JR; Zivin RA; Jolliffe L; Bluestone JA
    Transplantation; 1994 Jun; 57(11):1537-43. PubMed ID: 8009586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.
    Palacios R
    Eur J Immunol; 1985 Jul; 15(7):645-51. PubMed ID: 3924633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex.
    Ceuppens JL; Bloemmen FJ; Van Wauwe JP
    J Immunol; 1985 Dec; 135(6):3882-6. PubMed ID: 2933454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accessory cell-T cell interactions involved in anti-CD3-induced T4 and T8 cell proliferation: analysis with monoclonal antibodies.
    Geppert TD; Lipsky PE
    J Immunol; 1986 Nov; 137(10):3065-73. PubMed ID: 3095421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of T cell unresponsiveness by anti-CD3 antibodies occurs independently of co-stimulatory functions.
    Andris F; Van Mechelen M; De Mattia F; Baus E; Urbain J; Leo O
    Eur J Immunol; 1996 May; 26(5):1187-95. PubMed ID: 8647186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human IgG2 variants of chimeric anti-CD3 are nonmitogenic to T cells.
    Cole MS; Anasetti C; Tso JY
    J Immunol; 1997 Oct; 159(7):3613-21. PubMed ID: 9317161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cells in mice expressing a transgenic human TCR beta chain get positively selected but cannot be activated in the periphery by signaling through TCR.
    Pasare C; Mukherjee P; Verhoef A; Bansal P; Mendiratta SK; George A; Lamb JR; Rath S; Bal V
    Int Immunol; 2001 Jan; 13(1):53-62. PubMed ID: 11133834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala).
    Herold KC; Burton JB; Francois F; Poumian-Ruiz E; Glandt M; Bluestone JA
    J Clin Invest; 2003 Feb; 111(3):409-18. PubMed ID: 12569167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.
    Verwilghen J; Baroja ML; Van Vaeck F; Van Damme J; Ceuppens JL
    Immunology; 1991 Feb; 72(2):269-76. PubMed ID: 1826671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to CD44 trigger effector functions of human T cell clones.
    Galandrini R; Albi N; Tripodi G; Zarcone D; Terenzi A; Moretta A; Grossi CE; Velardi A
    J Immunol; 1993 May; 150(10):4225-35. PubMed ID: 8097750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.